New developments in anti-platelet therapies: potential use of CD39/vascular ATP diphosphohydrolase in thrombotic disorders.

Qawi, I

New developments in anti-platelet therapies: potential use of CD39/vascular ATP diphosphohydrolase in thrombotic disorders. [electronic resource] - Current drug targets Nov 2000 - 285-96 p. digital

Publication Type: Journal Article; Review

1389-4501

10.2174/1389450003349173 doi


Adenosine Triphosphatases--metabolism
Animals
Antigens, CD--metabolism
Apyrase--metabolism
Cyclooxygenase Inhibitors--pharmacology
Dipyridamole--pharmacology
Humans
Platelet Activation--drug effects
Platelet Aggregation Inhibitors--pharmacology
Platelet Membrane Glycoproteins--drug effects
Thrombosis--drug therapy